September 22, 2023
Loading...
You are here:  Home  >  Health Care & Life Science  >  Current Article

FTC pauses suit against Amgen on $28B acquisition

IN THIS ARTICLE

Amgen's new research and development facility in San Francisco. (courtesy photo) The Federal Trade Commission has put a pause on its lawsuit against Thousand Oaks-based Amgen’s acquisition of Horizon Therapeutics to allow time for the FTC to consider a settlement.  If a settlement is agreed to, then this legal saga between Amgen and the FTC…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.